Randomized phase II trial comparing every-3-week carboplatin/paclitaxel (C/P) versus every-3-week C with weekly P in advanced non-small cell lung cancer (NSCLC)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7073-7073
Keyword(s):
Phase Ii
◽